A*STAR Infectious Diseases Labs (A*STAR IDL)
Molecules to medicine
19 Apr 2023Leveraging on its public sector and industry collaborations, A*STAR and the Experimental Drug Development Centre hold the keys to effective drug discovery and development.
The war of the (malarial) roses
30 Mar 2023Drug-resistant malarial parasites form flower-like structures to shield themselves from attack by antimalarial drugs and the immune system.
In support of the groundbreakers
3 Mar 2023In 2023, the National Research Foundation Singapore selected 10 A*STAR researchers to be a part of its competitive Investigatorship and Fellowship grant programmes.
Are Singaporeans vulnerable to evolving viruses?
26 Dec 2022A profile of the immune responses from Singaporean patients recovered from COVID-19 has revealed an urgent need to update vaccines against new viral variants.
Why remdesivir works for some COVID-19 patients but not others
23 Jun 2022Remdesivir treatment is more likely to be successful in COVID-19 patients who are naturally able to mount a strong immune response against infections.
A COVID-19 test as good as gold
3 Jun 2022A*STAR researchers create a next-generation, ultrasensitive COVID-19 rapid test powered by gold nanoparticles.
